ClassID:

114710

C12Y201/01063 - CPC Classification

Classification description:

Transferases transferring one-carbon groups (2.1); Methyltransferases (2.1.1) Methylated-DNA-[protein]-cysteine S-methyltransferase (2.1.1.63), i.e. O6-methylguanine-DNA methyltransferase

Recent Application in this class:
#1
20250339559
2025-11-06

BASE EDITING-MEDIATED READTHROUGH OF PREMATURE TERMINATION CODONS (BERT)

#2
20250057973
2025-02-20

Exosomes for treating glioblastoma multiforme and manufacturing method thereof

#3
20240368582
2024-11-07

MODIFICATION OF EPOR-ENCODING NUCLEIC ACIDS

#4
20210263034
2021-08-26

DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT

#5
20210163899
2021-06-03

Fusion proteins for the detection of apoptosis

#6
20200319191
2020-10-08

MOLECULAR PROFILING FOR CANCER

#7
20190265242
2019-08-29

Quantifying MGMT protein for optimal cancer therapy of glioblastoma

#8
20190056406
2019-02-21

SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein

#9
20190008934
2019-01-10

Universal N-glycan binding reagent

#10
20180045727
2018-02-15

MOLECULAR PROFILING FOR CANCER

#11
20170138959
2017-05-18

Deglycosylation reagents and methods

#12
20170128554
2017-05-11

Universal N-glycan binding reagent

#13
20170088843
2017-03-30

MGMT-based method for obtaining high yeilds of recombinant protein expression

#14
20170088830
2017-03-30

Nucleic acid-guided ordered protein assemblies and methods

#15
20160334408
2016-11-17

SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein

#16
20160017367
2016-01-21

MGMT-based method for obtaining high yields of recombinant protein expression

#17
20150140022
2015-05-21

Photoimmunoconjugates for use in photodynamic therapy

#18
20130309747
2013-11-21

MGMT-based method for obtaining high yields of recombinant protein expression

#19
20100317722
2010-12-16

Nucleic acid sequences comprising NF-κB binding site within O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter region and uses thereof for the treatment of cancer and immune-related disorders